michigan hypertension core curriculum - State of Michigan
michigan hypertension core curriculum - State of Michigan
michigan hypertension core curriculum - State of Michigan
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Hypertension. Aug 2003;42(2):161-165.<br />
25. Logan AG, Perlikowski SM, Mente A, et al. High prevalence <strong>of</strong> unrecognized sleep apnoea in<br />
drug-resistant <strong>hypertension</strong>. J Hypertens. Dec 2001;19(12):2271-2277.<br />
26. Becker HF, Jerrentrup A, Ploch T, et al. Effect <strong>of</strong> nasal continuous positive airway pressure<br />
treatment on blood pressure in patients with obstructive sleep apnea. Circulation. Jan 7<br />
2003;107(1):68-73.<br />
27. Fong MW, Filippone JD, Beck GR, Katz MG, Bisognano JD. Improving care in resistant<br />
<strong>hypertension</strong>: medication trends and nonpharmacologic strategies in a specialty clinic. Am J<br />
Cardiovasc Drugs. 2007;7(6):449-452.<br />
28. Sica DA. Chlorthalidone: has it always been the best thiazide-type diuretic? Hypertension. Mar<br />
2006;47(3):321-322.<br />
29. Finnerty FA, Jr., Maxwell MH, Lunn J, Moser M. Long-term effects <strong>of</strong> furosemide and<br />
hydrochlorothiazide in patients with essential <strong>hypertension</strong> a two-year comparison <strong>of</strong> efficacy<br />
and safety. Angiology. Feb 1977;28(2):125-133.<br />
30. Nishizaka MK, Zaman MA, Calhoun DA. Efficacy <strong>of</strong> low-dose spironolactone in subjects with<br />
resistant <strong>hypertension</strong>. Am J Hypertens. Nov 2003;16(11 Pt 1):925-930.<br />
31. Eide IK, Torjesen PA, Drolsum A, Babovic A, Lilledahl NP. Low-renin status in therapy-resistant<br />
<strong>hypertension</strong>: a clue to efficient treatment. J Hypertens. Nov 2004;22(11):2217-2226.<br />
32. Nishizaka MK, Calhoun DA. The role <strong>of</strong> aldosterone antagonists in the management <strong>of</strong> resistant<br />
<strong>hypertension</strong>. Curr Hypertens Rep. Oct 2005;7(5):343-347.<br />
33. Saha C, Eckert GJ, Ambrosius WT, et al. Improvement in blood pressure with inhibition <strong>of</strong> the<br />
epithelial sodium channel in blacks with <strong>hypertension</strong>. Hypertension. Sep 2005;46(3):481-487.<br />
34. Chapman N, Dobson J, Wilson S, et al. Effect <strong>of</strong> spironolactone on blood pressure in subjects<br />
with resistant <strong>hypertension</strong>. Hypertension. Apr 2007;49(4):839-845.<br />
35. Hermida RC, Ayala DE, Calvo C, et al. Effects <strong>of</strong> time <strong>of</strong> day <strong>of</strong> treatment on ambulatory blood<br />
pressure pattern <strong>of</strong> patients with resistant <strong>hypertension</strong>. Hypertension. Oct 2005;46(4):1053-<br />
1059.<br />
36. Nishizaka MK, Calhoun DA. Use <strong>of</strong> aldosterone antagonists in resistant <strong>hypertension</strong>. J Clin<br />
Hypertens (Greenwich). Aug 2004;6(8):458-460.<br />
37. Saseen JJ, Carter BL, Brown TE, Elliott WJ, Black HR. Comparison <strong>of</strong> nifedipine alone and with<br />
diltiazem or verapamil in <strong>hypertension</strong>. Hypertension. Jul 1996;28(1):109-114.<br />
234 Hypertension Core Curriculum